Dapirolizumab

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Dapirolizumab is a PEG-free antigen-binding (Fab') fragment that binds CD40L (CD154) and lacks a functional Fc domain. Dapirolizumab inhibits CD40L-dependent immune responses without causing thrombotic complications and can be used in research related to systemic lupus erythematosus.

For research use only. We do not sell to patients.

  • Purity : 99.66%
  • CAS No.: 2235418-88-7
  • Molecular Weight:145.5 kDa
  • Storage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00